Publications

1. Ibrahim SH, Kohli R, Gores GJ. Mechanisms of lipotoxicity in NAFLD and clinical implications. J Pediatr Gastroenterol Nutr. 2011 Aug; 53(2):131-40. 2167818
   View PubMed
2. Ibrahim SH, Zhang L, Freese DK. A 3-year-old with immunoglobulin G4-associated cholangitis. J Pediatr Gastroenterol Nutr. 2011 Jul; 53(1):109-11. 2172190
   View PubMed
3. Ibrahim SH, Lindor KD. Current management of primary sclerosing cholangitis in pediatric patients. Paediatr Drugs. 2011 Apr 1; 13(2):87-95. 2151585
   View PubMed
4. Ibrahim SH, Akazawa Y, Cazanave SC, Bronk SF, Elmi NA, Werneburg NW, Billadeau DD, Gores GJ. Glycogen synthase kinase-3 (GSK-3) inhibition attenuates hepatocyte lipoapoptosis. J Hepatol. 2011 Apr; 54(4):765-72. Epub 2010 Nov 23. 2158064
   View PubMed
5. Ibrahim SH, Voigt RG, Katusic SK, Weaver AL, Barbaresi WJ. Incidence of gastrointestinal symptoms in children with autism: a population-based study. Pediatrics. 2009 Aug; 124(2):680-6. Epub 2009 Jul 27. 1956960
   View PubMed
6. Ibrahim SH, Smyrk TC, Faubion WA. Treatment of isolated gastric Crohn's disease with inhaled corticosteroids. Case Rep Gastroenterol. 2008; 2(3):363-8. Epub 2008 Nov 05. 2160306
   View PubMed